Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapiesSpencer C. Wei, James P. Allison|Proceedings of the National Academy of Sciences|2019Cited by 357
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C. Wei, Adam P. Silverman|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2